Company intelligence / Profile preview

Samarth Pharma

Mumbai, Maharashtra, India

Ownership: Private
Employees: ~600
Development stage: Other

Overview

Samarth Life Sciences develops, manufactures, and markets a broad range of critical care, anti-cancer, cardiovascular, and specialty drugs that are widely accepted in domestic and select international markets. The company is known for producing drugs for oncology and critical care, including proprietary liposomal and polymer-based delivery systems. Its portfolio is commercialized, and several products are leaders in their Indian market segments.

Therapeutic areas: EndocrinologyCardiovascularOtherOncologyNeurology
Modalities: Small moleculePolymer-drug conjugate therapyLiposomal drug deliveryHormoneProteinBiologic
Industry: Biotech

Beyond the preview

Go deeper on Samarth Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Samarth Pharma.

Explore the full profile